| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |